Boston Scientific revenue and financials
$42.19Change from previous close: −0.50%Absolute change: −$0.21
In the fiscal year ended December 2025, Boston Scientific reported revenue of $20.07B (+19.87% year over year). Net income was $2.89B, a net margin of 14.4%.
Fiscal year ending in December. Sources and method on the page Methodology and sources.
At a glance
- Revenue growth
- +19.87%
- 2025 vs 2024
- Net income growth
- +56.66%
- 2025 vs 2024
- Net margin
- 14.4%
- 2024: 11.0%
Financial data
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 5,442 | 5,203 | 5,286 | 5,065 | 5,061 | 4,663 | 4,561 | 4,209 | 4,120 | 3,856 | 3,725 | 3,527 |
| Cost of revenue | 1,606 | 1,602 | 1,614 | 1,535 | 1,651 | 1,467 | 1,475 | 1,317 | 1,279 | 1,219 | 1,158 | 1,112 |
| Gross profit | 3,836 | 3,601 | 3,672 | 3,530 | 3,410 | 3,196 | 3,086 | 2,892 | 2,841 | 2,637 | 2,567 | 2,415 |
| Selling, general and administrative | 1,803 | 1,781 | 1,834 | 1,741 | 1,716 | 1,597 | 1,612 | 1,562 | 1,446 | 1,364 | 1,379 | 1,242 |
| Research and development | 554 | 516 | 569 | 514 | 526 | 443 | 459 | 407 | 383 | 366 | 363 | 356 |
| Operating income | 1,246 | 1,072 | 1,041 | 1,050 | 943 | 937 | 790 | 718 | 799 | 693 | 617 | 609 |
| EBIT | 1,246 | 1,072 | 1,041 | 1,050 | 943 | 937 | 790 | 718 | 799 | 693 | 617 | 609 |
| EBITDA | 1,601 | 1,423 | 1,406 | 1,392 | 1,279 | 1,262 | 1,138 | 1,024 | 1,110 | 997 | 930 | 909 |
| Interest expense | 96.0 | 90.0 | 90.0 | 87.0 | 90.0 | 82.0 | 80.0 | 79.0 | 77.0 | 69.0 | 65.0 | 66.0 |
| Pre-tax income | 1,060 | 1,163 | 700 | 938 | 941 | 805 | 584 | 669 | 420 | 609 | 505 | 610 |
| Income tax | 155 | -176 | 30.0 | 183 | 146 | 133 | 23.0 | 200 | 98.0 | 115 | 1.0 | 105 |
| Net income | 907 | 1,341 | 672 | 755 | 797 | 674 | 565 | 469 | 324 | 495 | 505 | 505 |
| Net income to common shareholders | 907 | 1,341 | 672 | 755 | 797 | 674 | 565 | 469 | 324 | 495 | 505 | 505 |
| Basic EPS | 0.62 | 0.90 | 0.45 | 0.51 | 0.54 | 0.46 | 0.38 | 0.32 | 0.22 | 0.34 | 0.34 | 0.34 |
| Diluted EPS | 0.61 | 0.90 | 0.45 | 0.51 | 0.53 | 0.45 | 0.38 | 0.32 | 0.22 | 0.33 | 0.34 | 0.34 |
| Average shares (basic) | 1,470 | 1,485 | 1,483 | 1,482 | 1,480 | 1,477 | 1,474 | 1,473 | 1,471 | 1,468 | 1,465 | 1,465 |
| Average shares (diluted) | 1,475 | 1,495 | 1,496 | 1,496 | 1,494 | 1,493 | 1,490 | 1,487 | 1,484 | 1,482 | 1,477 | 1,475 |